Home

Sotac Pharmaceuticals Ltd PE Ratio

Image

Sotac Pharmaceuticals Ltd

NSE: SotacPharma.

PE

27.2

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Sotac Pharmaceuticals Ltd is 27.2 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Sotac Pharmaceuticals Ltd changed from 31.3 on March 2024 to 31.3 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Sotac Pharmaceuticals Ltd is ₹ 113.3 as of 14 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Sotac Pharmaceuticals Ltd

No data available

Company Fundamentals for Sotac Pharmaceuticals Ltd

Image

Sotac Pharmaceuticals Ltd

NSE: SotacPharma.

Share Price

₹ 113.3

5.30 (4.91%)

stock direction

Last updated on: Jan 14, 2025

Market Price of Sotac Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sotac Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025113.3
09 Jan 2025108
08 Jan 2025106.15
07 Jan 2025111.15
06 Jan 2025105.9
03 Jan 2025111
02 Jan 2025105.75
01 Jan 2025110.8
31 Dec 2024109.3
30 Dec 2024104.1

SWOT Analysis Of Sotac Pharmaceuticals Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Sotac Pharmaceuticals Ltd

Asset Value vs Market Value of Sotac Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Sotac Pharmaceuticals Ltd125.2
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Sotac Pharmaceuticals Ltd Explained

``

125.2

Market cap

4

Earnings

27.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sotac Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sotac Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Sotac Pharmaceuticals Ltd

No data available

* All values are in %

About Sotac Pharmaceuticals Ltd

  • Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of 'M/s Sotac Pharmaceuticals', pursuant to a Deed of Partnership dated October 28, 2015.
  • Thereafter 'M/s.
  • Sotac Pharmaceuticals' was converted from Partnership Firm to a Private Limited Company in the name of 'Sotac Pharmaceuticals Private Limited' dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat.
  • Later on, Company converted into a Public Limited Company and the name of Company was changed to 'Sotac Pharmaceuticals Limited' dated November 22, 2022 issued by Registrar of Companies, Ahmedabad. The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis.

Sotac Pharmaceuticals Ltd News Hub

Sotac Pharmaceuticals consolidated net profit rises 34.26% in the June 2024 quarter

Net profit of Sotac Pharmaceuticals rose 34.26% to Rs 1.45 crore in the quarter ended June 2024 as a

Read more

2024-08-13 00:00:00

Sotac Pharmaceuticals to conduct board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024

Read more

2024-08-09 00:00:00

Sotac Pharmaceuticals AGM scheduled

Sotac Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel

Read more

2024-08-30 00:00:00

Sotac Pharmaceuticals schedules board meeting

Sotac Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 October 202

Read more

2024-10-26 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sotac Pharmaceuticals Ltd

What is the current PE Ratio of Sotac Pharmaceuticals Ltd?

The Current PE Ratio of Sotac Pharmaceuticals Ltd is 27.24 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Sotac Pharmaceuticals Ltd last year?

The PE Ratio of Sotac Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 27.24, showing a year-on-year growth of -%.

What does the PE Ratio of Sotac Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Sotac Pharmaceuticals Ltd is 27.24. This ratio indicates that investors are willing to pay 27.24 times the earnings per share for each share of Sotac Pharmaceuticals Ltd.

What is the PE Ratio Growth of Sotac Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sotac Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -68.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions